Agendia Presents FLEX Study Data at ASBrS 2026 Showing Consistent MammaPrint + BluePrint Performance Across Diverse Basal-Type Breast Cancer Groups Agendia®, Inc., a recognized leader in precision oncology for breast cancer, has announced the presentation of new findings from its…
RestorixHealth and Industry Leaders Highlight the Legacy, Innovation, and Healing Power of Hyperbaric Medicine In the evolving landscape of modern healthcare, few therapies demonstrate the blend of historical significance and cutting-edge innovation as effectively as hyperbaric oxygen therapy (HBO2). Each…
E-Scopics Secures FDA Clearance for Enhanced Hepatoscope® Platform E-Scopics has announced a major advancement in liver disease diagnostics with the latest U.S. clearance from the U.S. Food and Drug Administration for its upgraded Hepatoscope platform. This milestone reflects the company’s…
Contineum Therapeutics, Inc. Reports Inducement Equity Grants Under Nasdaq Rule 5635(c)(4) Contineum Therapeutics a clinical-stage biopharmaceutical company focused on developing differentiated therapies for neuroscience, inflammation, and immunology (NI&I) indications, has announced the issuance of inducement equity awards to two newly…
Accendra Health to Announce First Quarter 2026 Financial Results on May 11 Accendra Health, has officially announced the date for the release of its financial results for the first quarter of 2026. The Company will publish its earnings report on…
Incyte Secures U.S. Food and Drug Administration Approval for Jakafi XR Incyte has announced a significant milestone with the approval of Jakafi XR™ (ruxolitinib) extended-release tablets by the U.S. Food and Drug Administration (FDA). This approval introduces a once-daily treatment…
Veradermics Prices Upsized Public Offering and Private Placement, Raising Over $400 Million Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative treatments for pattern hair loss, has announced the pricing of an upsized public offering alongside a…
Genentech to Showcase Ophthalmology Data at ARVO 2026 Genentech is set to present a substantial body of new research highlighting the strength and breadth of its ophthalmology portfolio at the ARVO Annual Meeting 2026, taking place May 3–7 in Denver.…
The Hidden Risks of Self-Diagnosis A persistent headache that refuses to ease. A cough that lingers longer than expected. A new or unfamiliar symptom that raises quiet concern. In moments like these, many people instinctively turn to the internet for…
Strategic partnership launches CIO Leadership Exchange to empower IT leaders with AI, data, and digital transformation expertise across community health centers nationwide The National Association of Community Health Centers (NACHC) and NextGen Healthcare have announced a strategic partnership aimed at…
Dentrix Ascend Introduces MCP Layer, Ushering in a New Era of AI-Driven Dental Practice Management Henry Schein One, a global leader in dental software and technology solutions, has announced a major advancement in its cloud-based platform, Dentrix Ascend. The company…
Henry Schein Orthodontics Enhances Myofunctional Offerings with Froggymouth® Introduction Henry Schein Orthodontics (HSO), the orthodontics division of Henry Schein, Inc., has announced the availability of Froggymouth®, an innovative myofunctional device designed to assist in the management of orofacial dysfunctions. Manufactured…